(Q41004721)

25 September 2017

Modifications of oxido-reductase activities in adriamycin-resistant leukaemia K562 cells (English)

1 reference

25 September 2017

1 reference

Denis-Gay M

1

1 reference

25 September 2017

Petit JM

series ordinal

2

1 reference

25 September 2017

Mazat JP

series ordinal

3

1 reference

25 September 2017

Ratinaud MH

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

25 September 2017

Biochemical Pharmacology

1 reference

25 September 2017

56

1 reference

25 September 2017

451-457

1 reference

25 September 2017

4

1 reference

Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Subcellular effects of adriamycin in the heart: a concise review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Resistance to multiple chemotherapeutic agents in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

The molecular nature of mutations induced by adriamycin at the hprt locus of V79 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

The biochemistry of P-glycoprotein-mediated multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Biochemical and molecular investigations in respiratory chain deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Multidrug resistance and mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Effect of adriamycin on heart mitochondrial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lacticacidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Relationship between culture conditions and the dependency on mitochondrial function of mammalian cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Control of oxidative phosphorylation in rat muscle mitochondria: implications for mitochondrial myopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

Adriamycin-induced DNA adducts inhibit the DNA interactions of transcription factors and RNA polymerase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900084-7

10.1016/S0006-2952(98)00084-7

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference